首页 > 最新文献

International Journal of Endocrinology and Metabolism最新文献

英文 中文
Maternal Exposure to D-galactose Reduces Ovarian Reserve in Female Rat Offspring Later in Life. 母鼠暴露于d -半乳糖会降低母鼠后代日后卵巢储备功能。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-05-30 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-123206
Marzieh Rostami Dovom, Mahsa Noroozzadeh, Nariman Mosaffa, Abbas Piryaei, Azita Zadeh-Vakili, Mohammad-Amin Aabdollahifar, Maryam Rahmati, Mahbanoo Farhadi-Azar, Fahimeh Ramezani Tehrani

Background: Embryonic life is critical for the formation of ovaries in mammals, and the intrauterine environment may affect ovarian reserve.

Objectives: The present study aimed to investigate the impact of prenatal D-galactose exposure on ovarian reserve in female rat offspring in their later lives.

Methods: Ten pregnant Wistar rats were randomly divided into two groups. In one group, rats were fed with 35% D-galactose-enriched food from the third day to the end of pregnancy, and in the other group, rats were fed with a standard diet throughout pregnancy. Female offspring (prenatally galactose-exposed rats and non-exposed control rats) were examined in terms of hormonal levels [anti-Mullerian hormones (AMH), follicle-stimulating hormone (FSH), and estradiol (E2)] and ovarian histology at 45 - 50, 105 - 110, and 180 - 185 days of their age.

Results: The number of primordial follicles significantly decreased time-dependently in prenatally galactose-exposed rats compared to controls (P-value = 0.002). In addition, decreases in AMH (3.25 vs. 7.5 ng/mL; P = 0.000) and E2 (7.9 vs. 19.5 pg/mL; P = 0.000) and increases in FSH (6.5 vs. 0.8 mIU/mL; P < 0.007) were observed in galactose-exposed rats compared to controls at 45 - 50 days of age.

Conclusions: Prenatal exposure to D-galactose negatively affects ovarian reserve in female rats in their later lives. However, further investigation is needed to confirm our findings and explore underlying mechanisms.

背景:胚胎生命对哺乳动物卵巢的形成至关重要,而宫内环境可能影响卵巢储备。目的:探讨产前d -半乳糖暴露对雌性大鼠后代卵巢储备功能的影响。方法:10只Wistar妊娠大鼠随机分为两组。其中一组大鼠从妊娠第3天至妊娠结束时喂食富含35% d -半乳糖的食物,另一组大鼠在妊娠期间喂食标准饮食。雌性后代(产前暴露于半乳糖的大鼠和未暴露于乳糖的对照大鼠)在其45 - 50、105 - 110和180 - 185天龄时进行激素水平[抗苗勒管激素(AMH)、促卵泡激素(FSH)和雌二醇(E2)]和卵巢组织学检查。结果:与对照组相比,产前暴露于半乳糖的大鼠原始卵泡数量明显减少(p值= 0.002)。此外,AMH降低(3.25 vs. 7.5 ng/mL;P = 0.000)和E2 (7.9 vs. 19.5 pg/mL;P = 0.000)和促卵泡刺激素升高(6.5 vs 0.8 mIU/mL;P < 0.007),暴露于半乳糖的大鼠在45 - 50日龄时与对照相比。结论:产前暴露于d -半乳糖会对雌性大鼠日后的卵巢储备产生负面影响。然而,需要进一步的研究来证实我们的发现并探索潜在的机制。
{"title":"Maternal Exposure to D-galactose Reduces Ovarian Reserve in Female Rat Offspring Later in Life.","authors":"Marzieh Rostami Dovom,&nbsp;Mahsa Noroozzadeh,&nbsp;Nariman Mosaffa,&nbsp;Abbas Piryaei,&nbsp;Azita Zadeh-Vakili,&nbsp;Mohammad-Amin Aabdollahifar,&nbsp;Maryam Rahmati,&nbsp;Mahbanoo Farhadi-Azar,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.5812/ijem-123206","DOIUrl":"https://doi.org/10.5812/ijem-123206","url":null,"abstract":"<p><strong>Background: </strong>Embryonic life is critical for the formation of ovaries in mammals, and the intrauterine environment may affect ovarian reserve.</p><p><strong>Objectives: </strong>The present study aimed to investigate the impact of prenatal D-galactose exposure on ovarian reserve in female rat offspring in their later lives.</p><p><strong>Methods: </strong>Ten pregnant Wistar rats were randomly divided into two groups. In one group, rats were fed with 35% D-galactose-enriched food from the third day to the end of pregnancy, and in the other group, rats were fed with a standard diet throughout pregnancy. Female offspring (prenatally galactose-exposed rats and non-exposed control rats) were examined in terms of hormonal levels [anti-Mullerian hormones (AMH), follicle-stimulating hormone (FSH), and estradiol (E2)] and ovarian histology at 45 - 50, 105 - 110, and 180 - 185 days of their age.</p><p><strong>Results: </strong>The number of primordial follicles significantly decreased time-dependently in prenatally galactose-exposed rats compared to controls (P-value = 0.002). In addition, decreases in AMH (3.25 vs. 7.5 ng/mL; P = 0.000) and E2 (7.9 vs. 19.5 pg/mL; P = 0.000) and increases in FSH (6.5 vs. 0.8 mIU/mL; P < 0.007) were observed in galactose-exposed rats compared to controls at 45 - 50 days of age.</p><p><strong>Conclusions: </strong>Prenatal exposure to D-galactose negatively affects ovarian reserve in female rats in their later lives. However, further investigation is needed to confirm our findings and explore underlying mechanisms.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e123206"},"PeriodicalIF":2.1,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/70/ijem-20-2-123206.PMC9383541.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40631122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones? 增强幸福感与甲状腺毒症相关:甲状腺激素的忽视作用?
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-05-29 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-127230
Petros Perros, Laszlo Hegedus

Context: Thyrotoxicosis may be associated with a better sense of well-being than in the euthyroid state, though this is not widely recognised.

Evidence acquisition: A comprehensive literature search in PubMed and Google Scholar, was performed to identify studies investigating factors influencing well-being, mood, and psychological features associated with elevated thyroid hormones.

Results: Enhanced well-being associated with thyrotoxicosis has been described, although the evidence is observational and anecdotal.

Conclusions: Enhanced well-being associated with thyrotoxicosis is probably experienced in a minority of patients and may explain why some seek overtreatment with thyroid hormones and report significant improvement on larger than physiological thyroid hormone replacement regimens. It may also explain why some patients with hyperthyroidism (usually due to Graves' disease) are reluctant to adhere to anti-thyroid medication.

背景:甲状腺毒症患者可能比甲状腺功能正常的人有更好的幸福感,尽管这一点尚未得到广泛认可。证据获取:在PubMed和Google Scholar中进行了全面的文献检索,以确定与甲状腺激素升高相关的影响幸福感、情绪和心理特征的因素。结果:虽然证据是观察性和轶事性的,但已经描述了甲状腺毒症患者的幸福感增强。结论:与甲状腺毒症相关的幸福感增强可能在少数患者中出现,这可能解释了为什么有些患者寻求甲状腺激素的过度治疗,并报告比生理性甲状腺激素替代方案有显著改善。这也可以解释为什么一些甲亢患者(通常是由于格雷夫斯病)不愿意坚持抗甲状腺药物治疗。
{"title":"Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones?","authors":"Petros Perros,&nbsp;Laszlo Hegedus","doi":"10.5812/ijem-127230","DOIUrl":"https://doi.org/10.5812/ijem-127230","url":null,"abstract":"<p><strong>Context: </strong>Thyrotoxicosis may be associated with a better sense of well-being than in the euthyroid state, though this is not widely recognised.</p><p><strong>Evidence acquisition: </strong>A comprehensive literature search in PubMed and Google Scholar, was performed to identify studies investigating factors influencing well-being, mood, and psychological features associated with elevated thyroid hormones.</p><p><strong>Results: </strong>Enhanced well-being associated with thyrotoxicosis has been described, although the evidence is observational and anecdotal.</p><p><strong>Conclusions: </strong>Enhanced well-being associated with thyrotoxicosis is probably experienced in a minority of patients and may explain why some seek overtreatment with thyroid hormones and report significant improvement on larger than physiological thyroid hormone replacement regimens. It may also explain why some patients with hyperthyroidism (usually due to Graves' disease) are reluctant to adhere to anti-thyroid medication.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e127230"},"PeriodicalIF":2.1,"publicationDate":"2022-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/14/ijem-20-2-127230.PMC9375936.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40631120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contributing Factors for Calcium Changes During Hospitalization in COVID-19: A Longitudinal Study. COVID-19住院期间钙变化的影响因素:一项纵向研究
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-04-30 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-122378
Sima Hashemipour, Somaieh Kiani, Pouria Shahsavari, Milad Badri, Arefeh Ghobadi, Seyyed Mohammad Reza Hadizadeh Khairkhahan, Mehdi Ranjbaran, Maryam Gheraati

Background: Hypocalcemia is highly prevalent in Coronavirus disease 2019 (COVID-19). There is limited evidence about the course and roles of different parameters in the occurrence of new or worsening hypocalcemia.

Objectives: This prospective longitudinal study was conducted on hospitalized COVID-19 patients in Qazvin, Iran, in 2021.

Methods: Serum levels of calcium, albumin, parathormone (PTH), 25(OH)D (vitamin D), magnesium, and phosphate were assessed on the first day (time one), as well as fourth to sixth days (time two) of hospitalization. Paired t-test, McNemar's test, and multivariate logistic regression test were used to compare data at two times and evaluating the independent roles of different variables in the occurrence or worsening of hypocalcemia.

Results: Out of a total of 123 participants, 102 patients completed the study. The mean serum calcium level significantly decreased from 8.32 ± 0.52 mg/dL to 8.02 ± 0.55 mg/dL at time two compared to time one (P < 0.001). Also, we witnessed new or worsening hypocalcemia at time two in 44 (55%) patients with normal serum calcium or mild hypocalcemia at time one (P < 0.001). The PTH level decreased from 42.17 ± 27.20 pg/mL to 31.28 ± 23.42 pg/mL (P < 0.001). The decrease in albumin and PTH levels was an independent significant factor in the occurrence or worsening of hypocalcemia at time two (OR = 1.27; 95% CI: 1.10 - 1.46; P = 0.001 for each 1 g/L decrement in albumin and OR = 1.29; 95% CI: 1.03 - 1.62; P = 0.026 for each 10 pg/mL decrement in PTH). Vitamin D deficiency or changes during hospitalization did not have a significant role in new or worsening hypocalcemia.

Conclusions: Decreased PTH secretion and hypoalbuminemia have significant roles in the occurrence of new or worsening hypocalcemia during hospitalization due to COVID-19.

背景:低钙血症在2019冠状病毒病(COVID-19)中非常普遍。关于不同参数在新发或恶化低钙血症发生中的过程和作用的证据有限。目的:本前瞻性纵向研究于2021年在伊朗加兹温住院的COVID-19患者进行。方法:分别于住院第1天(时间1)及第4 ~ 6天(时间2)测定患者血清钙、白蛋白、甲状旁腺激素(PTH)、25(OH)D(维生素D)、镁、磷酸盐水平。采用配对t检验、McNemar检验和多变量logistic回归检验对两次数据进行比较,评价不同变量在低钙血症发生或恶化中的独立作用。结果:在123名参与者中,102名患者完成了研究。与第1次相比,第2次的平均血钙水平由8.32±0.52 mg/dL显著降低至8.02±0.55 mg/dL (P < 0.001)。此外,我们发现44例(55%)血清钙正常或第一次出现轻度低钙血症的患者在第二次出现新的或恶化的低钙血症(P < 0.001)。PTH水平由42.17±27.20 pg/mL降至31.28±23.42 pg/mL (P < 0.001)。白蛋白和甲状旁腺激素水平的降低是第二次低钙血症发生或恶化的独立显著因素(or = 1.27;95% ci: 1.10 - 1.46;白蛋白每减少1 g/L, P = 0.001, OR = 1.29;95% ci: 1.03 - 1.62;PTH每降低10pg /mL P = 0.026)。维生素D缺乏或住院期间的变化在新的或恶化的低钙血症中没有显著作用。结论:PTH分泌减少和低白蛋白血症在COVID-19患者住院期间新发或加重低钙血症的发生中起重要作用。
{"title":"Contributing Factors for Calcium Changes During Hospitalization in COVID-19: A Longitudinal Study.","authors":"Sima Hashemipour,&nbsp;Somaieh Kiani,&nbsp;Pouria Shahsavari,&nbsp;Milad Badri,&nbsp;Arefeh Ghobadi,&nbsp;Seyyed Mohammad Reza Hadizadeh Khairkhahan,&nbsp;Mehdi Ranjbaran,&nbsp;Maryam Gheraati","doi":"10.5812/ijem-122378","DOIUrl":"https://doi.org/10.5812/ijem-122378","url":null,"abstract":"<p><strong>Background: </strong>Hypocalcemia is highly prevalent in Coronavirus disease 2019 (COVID-19). There is limited evidence about the course and roles of different parameters in the occurrence of new or worsening hypocalcemia.</p><p><strong>Objectives: </strong>This prospective longitudinal study was conducted on hospitalized COVID-19 patients in Qazvin, Iran, in 2021.</p><p><strong>Methods: </strong>Serum levels of calcium, albumin, parathormone (PTH), 25(OH)D (vitamin D), magnesium, and phosphate were assessed on the first day (time one), as well as fourth to sixth days (time two) of hospitalization. Paired t-test, McNemar's test, and multivariate logistic regression test were used to compare data at two times and evaluating the independent roles of different variables in the occurrence or worsening of hypocalcemia.</p><p><strong>Results: </strong>Out of a total of 123 participants, 102 patients completed the study. The mean serum calcium level significantly decreased from 8.32 ± 0.52 mg/dL to 8.02 ± 0.55 mg/dL at time two compared to time one (P < 0.001). Also, we witnessed new or worsening hypocalcemia at time two in 44 (55%) patients with normal serum calcium or mild hypocalcemia at time one (P < 0.001). The PTH level decreased from 42.17 ± 27.20 pg/mL to 31.28 ± 23.42 pg/mL (P < 0.001). The decrease in albumin and PTH levels was an independent significant factor in the occurrence or worsening of hypocalcemia at time two (OR = 1.27; 95% CI: 1.10 - 1.46; P = 0.001 for each 1 g/L decrement in albumin and OR = 1.29; 95% CI: 1.03 - 1.62; P = 0.026 for each 10 pg/mL decrement in PTH). Vitamin D deficiency or changes during hospitalization did not have a significant role in new or worsening hypocalcemia.</p><p><strong>Conclusions: </strong>Decreased PTH secretion and hypoalbuminemia have significant roles in the occurrence of new or worsening hypocalcemia during hospitalization due to COVID-19.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e122378"},"PeriodicalIF":2.1,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/5d/ijem-20-2-122378.PMC9375939.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40630661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Type 2 Diabetes Health Literacy Assessment Tool: Translation and Psychometric Evaluation of the Iranian Version. 2型糖尿病健康素养评估工具:伊朗版的翻译和心理测量学评估
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-04-29 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-116983
Ali Ahmadi, Shamsaddin Niknami, Mohtasham Ghaffari

Background: Adequate health literacy can lead to self-care behaviors among patients with type 2 diabetes (T2D). Although there is an instrument for measuring the health literacy of patients with diabetes, there is no Persian version of the instrument in Iran.

Objectives: The aim of this study was to translate the Chinese Health Literacy Scale for Diabetes (CHLSD) and evaluate the psychometric parameters of the Iranian version.

Methods: In this methodological study, using a standard forward-backward translation procedure, the original English language version of the questionnaire was translated into Persian. Face and content validity steps were performed for psychometric measurements. To perform construct (convergent) validity, a cross-sectional study was carried out with the participation of T2D patients admitted to the diabetes clinic (aged over 25 years old). To test the reliability, internal consistency was assessed by Kuder-Richardson (K-R) coefficient, and a test-retest was performed by Spearman correlation coefficient.

Results: A total of 283 patients with T2D (mean age: 52.4 years and standard deviation: 11.5) were included in the study. The factor loadings of the variables were checked by calculating the correlation value of the characteristics of a construct with that construct, whose value was greater than 0.4. The K-R coefficients for the whole instrument and its four subscales (remembering, application, analysis, and comprehension) were 0.8, 0.71, 0.73, 0.87, and 0.89, respectively. Re-testing of the instrument with an interval of two weeks indicated the acceptable stability of the instrument (ICC ≥ 0.8).

Conclusions: Our findings showed that the Iranian version of CHLSD is a valid and reliable instrument for measuring the health literacy in patients with diabetes.

背景:充分的健康素养可以提高2型糖尿病患者的自我保健行为。虽然有一种测量糖尿病患者健康素养的工具,但伊朗没有波斯语版本的工具。目的:本研究的目的是翻译中国糖尿病健康素养量表(CHLSD),并评估伊朗版本的心理测量参数。方法:在本方法学研究中,采用标准的前向后翻译程序,将问卷的原始英文版本翻译成波斯语。对心理测量进行了面部和内容效度步骤。为了执行结构(收敛)效度,我们对在糖尿病诊所就诊的T2D患者(年龄在25岁以上)进行了横断面研究。为检验信度,采用库德-理查德森(K-R)系数评估内部一致性,采用Spearman相关系数进行重测。结果:共纳入283例T2D患者,平均年龄52.4岁,标准差11.5。通过计算构念特征与构念的相关值来检验各变量的因子负荷,其相关值大于0.4。整个工具及其四个子量表(记忆、应用、分析和理解)的K-R系数分别为0.8、0.71、0.73、0.87和0.89。仪器每隔两周重新测试一次,表明仪器的稳定性可接受(ICC≥0.8)。结论:伊朗版CHLSD是一种有效、可靠的糖尿病患者健康素养测量工具。
{"title":"Type 2 Diabetes Health Literacy Assessment Tool: Translation and Psychometric Evaluation of the Iranian Version.","authors":"Ali Ahmadi,&nbsp;Shamsaddin Niknami,&nbsp;Mohtasham Ghaffari","doi":"10.5812/ijem-116983","DOIUrl":"https://doi.org/10.5812/ijem-116983","url":null,"abstract":"<p><strong>Background: </strong>Adequate health literacy can lead to self-care behaviors among patients with type 2 diabetes (T2D). Although there is an instrument for measuring the health literacy of patients with diabetes, there is no Persian version of the instrument in Iran.</p><p><strong>Objectives: </strong>The aim of this study was to translate the Chinese Health Literacy Scale for Diabetes (CHLSD) and evaluate the psychometric parameters of the Iranian version.</p><p><strong>Methods: </strong>In this methodological study, using a standard forward-backward translation procedure, the original English language version of the questionnaire was translated into Persian. Face and content validity steps were performed for psychometric measurements. To perform construct (convergent) validity, a cross-sectional study was carried out with the participation of T2D patients admitted to the diabetes clinic (aged over 25 years old). To test the reliability, internal consistency was assessed by Kuder-Richardson (K-R) coefficient, and a test-retest was performed by Spearman correlation coefficient.</p><p><strong>Results: </strong>A total of 283 patients with T2D (mean age: 52.4 years and standard deviation: 11.5) were included in the study. The factor loadings of the variables were checked by calculating the correlation value of the characteristics of a construct with that construct, whose value was greater than 0.4. The K-R coefficients for the whole instrument and its four subscales (remembering, application, analysis, and comprehension) were 0.8, 0.71, 0.73, 0.87, and 0.89, respectively. Re-testing of the instrument with an interval of two weeks indicated the acceptable stability of the instrument (ICC ≥ 0.8).</p><p><strong>Conclusions: </strong>Our findings showed that the Iranian version of CHLSD is a valid and reliable instrument for measuring the health literacy in patients with diabetes.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e116983"},"PeriodicalIF":2.1,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/96/a9/ijem-20-2-116983.PMC9375938.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40630660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report. 特立帕肽治疗青少年骨质疏松-假性胶质瘤综合征(OPPG)的临床反应:1例报告。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-04-27 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-121031
Ali Homaei, Victoria Chegini, Fatemeh Saffari

Introduction: Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive disorder characterized by severe osteoporosis and eye abnormalities that leads to vision loss. In this study, we report the outcome of a short period of treatment with teriparatide in one patient with OPPG.

Case presentation: The patient was a 17-year-old girl who suffered a bone fracture at the age of two and was diagnosed with OPPG at the age of three. Genetic testing was performed for the patient, and a novel homozygous nonsense mutation (c.351G>A) in exon 2 of the LRP5 gene was reported. She was treated with pamidronate, but the bone fracture increased, and the disability progressed. Therefore, at the age of 11 years and nine months, teriparatide was administered subcutaneously at a dose of 20 micrograms per day for four consecutive months. After the treatment with teriparatide, physical activity was achieved, and no further fractures were observed besides the gradual rise in bone mineral density (BMD) (from 0.532 to 0.711 gr/cm2 in lumbar spine and 0.372 to 0.635 gr/cm2 in femur neck).

Conclusions: In children and adolescents diagnosed with OPPG who do not respond to other conventional therapies, short courses of teriparatide therapy may be helpful.

骨质疏松-假性胶质瘤综合征(osteoporosis -pseudoglioma syndrome, OPPG)是一种罕见的常染色体隐性遗传病,其特征是严重骨质疏松和眼睛异常,导致视力丧失。在这项研究中,我们报告了一名OPPG患者短期使用特立帕肽治疗的结果。病例介绍:患者是一名17岁的女孩,她在2岁时骨折,3岁时被诊断为OPPG。对患者进行了基因检测,报告了LRP5基因外显子2的新型纯合无义突变(c.351G> a)。她接受帕米膦酸盐治疗,但骨折增加,残疾进展。因此,在11岁零9个月时,以每天20微克的剂量皮下注射特立帕肽,连续4个月。经特立帕肽治疗后,患者恢复体力活动,除骨密度(BMD)逐渐升高(腰椎从0.532至0.711 gr/cm2,股骨颈从0.372至0.635 gr/cm2)外,未见进一步骨折。结论:对于诊断为OPPG的儿童和青少年,如果对其他常规治疗没有反应,短期的特立帕肽治疗可能会有所帮助。
{"title":"Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report.","authors":"Ali Homaei,&nbsp;Victoria Chegini,&nbsp;Fatemeh Saffari","doi":"10.5812/ijem-121031","DOIUrl":"https://doi.org/10.5812/ijem-121031","url":null,"abstract":"<p><strong>Introduction: </strong>Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive disorder characterized by severe osteoporosis and eye abnormalities that leads to vision loss. In this study, we report the outcome of a short period of treatment with teriparatide in one patient with OPPG.</p><p><strong>Case presentation: </strong>The patient was a 17-year-old girl who suffered a bone fracture at the age of two and was diagnosed with OPPG at the age of three. Genetic testing was performed for the patient, and a novel homozygous nonsense mutation (c.351G>A) in exon 2 of the LRP5 gene was reported. She was treated with pamidronate, but the bone fracture increased, and the disability progressed. Therefore, at the age of 11 years and nine months, teriparatide was administered subcutaneously at a dose of 20 micrograms per day for four consecutive months. After the treatment with teriparatide, physical activity was achieved, and no further fractures were observed besides the gradual rise in bone mineral density (BMD) (from 0.532 to 0.711 gr/cm<sup>2</sup> in lumbar spine and 0.372 to 0.635 gr/cm<sup>2</sup> in femur neck).</p><p><strong>Conclusions: </strong>In children and adolescents diagnosed with OPPG who do not respond to other conventional therapies, short courses of teriparatide therapy may be helpful.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e121031"},"PeriodicalIF":2.1,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/42/ijem-20-2-121031.PMC9383542.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40647064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Network Associations Among Body Image, Lifestyle, Body Mass Index, and Quality of Life in Adolescents. 青少年身体形象、生活方式、身体质量指数与生活质量的网络关联
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-04-20 eCollection Date: 2022-04-01 DOI: 10.5812/ijem-123237
Sara Jalali-Farahani, Farid Zayeri, Fariba Zarani, Fereidoun Azizi, Parisa Amiri

Background: Body image is known as an important factor affecting different aspects of adolescents' health; however, its relationship with lifestyle, body mass index (BMI), and health-related quality of life (HRQoL) in Iranian adolescents has not been addressed in a conceptual model.

Objectives: This study aimed to investigate the network associations among body image, lifestyle, BMI, and HRQoL in adolescent boys and girls.

Methods: The present study examined 760 adolescents (15 - 18 years) from Tehran. Adolescents reported their weight and height, according to which the participants' BMIs were calculated. The adolescents' body image, lifestyle, and HRQoL were assessed using a set of questionnaires, including the Body Image Scale for Youth (BISY), Modifiable Activity Questionnaire (MAQ), Eating Habits Checklist, Eating Attitudes Test (EAT-26), and Pediatric Quality of Life Inventory (PedsQLTM).

Results: The participants' mean age and BMI were 16.5 ± 1.0 years and 22.4 ± 4.6 kg/m2, respectively. More than one-third of boys (39.9%) and less than a quarter of girls (22.6%) were overweight/obese. In the final model, body image was significantly and directly associated with physical activity, disordered eating, eating habits, and HRQoL in both genders (P < 0.05). Moreover, body image was directly correlated with screen time in boys (P = 0.012) and BMI in girls (P = 0.001). Body image was indirectly correlated with BMI by the mediating role of disordered eating in girls. Moreover, body image was indirectly associated with HRQoL by the mediating role of physical activity and eating habits in both genders and screen time only in boys.

Conclusions: The network associations among body image, lifestyle, BMI, and HRQoL revealed a gender-specific pattern among the study population. Body image was a significant determinant of lifestyle and HRQoL in both genders and excessive weight in girls. The present findings would contribute to designing and implementing relevant health promotion interventions.

背景:身体形象被认为是影响青少年健康各个方面的重要因素;然而,其与伊朗青少年的生活方式、身体质量指数(BMI)和健康相关生活质量(HRQoL)的关系尚未在概念模型中得到解决。目的:探讨青少年男女身体形象、生活方式、身体质量指数与HRQoL之间的网络关系。方法:本研究调查了来自德黑兰的760名青少年(15 - 18岁)。青少年报告了他们的体重和身高,并据此计算参与者的身体质量指数。采用青少年身体形象量表(BISY)、可修改活动问卷(MAQ)、饮食习惯清单、饮食态度测试(EAT-26)和儿童生活质量量表(PedsQLTM)对青少年的身体形象、生活方式和HRQoL进行评估。结果:参与者的平均年龄为16.5±1.0岁,BMI为22.4±4.6 kg/m2。超过三分之一的男孩(39.9%)和不到四分之一的女孩(22.6%)超重/肥胖。在最后的模型中,身体形象与身体活动、饮食失调、饮食习惯和HRQoL在两性中均有显著的直接相关(P < 0.05)。男孩的身体形象与屏幕时间直接相关(P = 0.012),女孩的身体质量指数(P = 0.001)。女孩的身体形象通过饮食失调的中介作用与BMI间接相关。此外,身体形象与HRQoL之间存在间接关联,在两性中,身体活动和饮食习惯都起到中介作用,而在男孩中,只有屏幕时间起到中介作用。结论:身体形象、生活方式、BMI和HRQoL之间的网络关联在研究人群中显示出一种性别特异性模式。身体形象是男女生活方式和HRQoL的重要决定因素,也是女孩超重的重要决定因素。本研究结果将有助于设计和实施相关的健康促进干预措施。
{"title":"Network Associations Among Body Image, Lifestyle, Body Mass Index, and Quality of Life in Adolescents.","authors":"Sara Jalali-Farahani,&nbsp;Farid Zayeri,&nbsp;Fariba Zarani,&nbsp;Fereidoun Azizi,&nbsp;Parisa Amiri","doi":"10.5812/ijem-123237","DOIUrl":"https://doi.org/10.5812/ijem-123237","url":null,"abstract":"<p><strong>Background: </strong>Body image is known as an important factor affecting different aspects of adolescents' health; however, its relationship with lifestyle, body mass index (BMI), and health-related quality of life (HRQoL) in Iranian adolescents has not been addressed in a conceptual model.</p><p><strong>Objectives: </strong>This study aimed to investigate the network associations among body image, lifestyle, BMI, and HRQoL in adolescent boys and girls.</p><p><strong>Methods: </strong>The present study examined 760 adolescents (15 - 18 years) from Tehran. Adolescents reported their weight and height, according to which the participants' BMIs were calculated. The adolescents' body image, lifestyle, and HRQoL were assessed using a set of questionnaires, including the Body Image Scale for Youth (BISY), Modifiable Activity Questionnaire (MAQ), Eating Habits Checklist, Eating Attitudes Test (EAT-26), and Pediatric Quality of Life Inventory (PedsQL<sup>TM</sup>).</p><p><strong>Results: </strong>The participants' mean age and BMI were 16.5 ± 1.0 years and 22.4 ± 4.6 kg/m<sup>2</sup>, respectively. More than one-third of boys (39.9%) and less than a quarter of girls (22.6%) were overweight/obese. In the final model, body image was significantly and directly associated with physical activity, disordered eating, eating habits, and HRQoL in both genders (P < 0.05). Moreover, body image was directly correlated with screen time in boys (P = 0.012) and BMI in girls (P = 0.001). Body image was indirectly correlated with BMI by the mediating role of disordered eating in girls. Moreover, body image was indirectly associated with HRQoL by the mediating role of physical activity and eating habits in both genders and screen time only in boys.</p><p><strong>Conclusions: </strong>The network associations among body image, lifestyle, BMI, and HRQoL revealed a gender-specific pattern among the study population. Body image was a significant determinant of lifestyle and HRQoL in both genders and excessive weight in girls. The present findings would contribute to designing and implementing relevant health promotion interventions.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 2","pages":"e123237"},"PeriodicalIF":2.1,"publicationDate":"2022-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/6d/ijem-20-2-123237.PMC9375937.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40631121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychotic Disorder as the First Manifestation of Addison Disease: A Case Report 以精神障碍为Addison病首发症状的一例报告
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.5812/ijem.121011
Zahra Momayez Sanat, M. Mohajeri-Tehrani
Introduction Addison disease is a relatively uncommon endocrine disease resulting from adrenal insufficiency. Psychiatric symptoms are among its rare primary and particularly isolated clinical symptoms. This report presents a case with adrenal insufficiency manifested by the psychotic syndrome. Case Presentation A 28-year-old Iranian female with a history of immune thrombocytopenic purpura (ITP) and asthma since childhood presented with a 13-month history of progressive depression with insomnia and nightmare symptoms. After being prescribed haloperidol, clomipramine, and clonazepam for eight months, abdominal pain and weight loss due to anorexia started. Her physical examination showed skin hyperpigmentation in the elbow, knee, ankle, and buccal mucosa. Physical examination and initial laboratory tests suggested adrenal insufficiency. Addison disease was confirmed according to the laboratory tests and abdominal CT. The symptoms were significantly improved using intravenous hydrocortisone treatment. The patient remained calm and had a normal sleep without depressive symptoms or psychosis after 72 hours of treatment. During one year of follow-up, the patient was in good general condition without psychological symptoms. Conclusions This report shows that psychotic disorder can be the first manifestation of Addison disease. Therefore, physicians should be informed about the neuropsychiatric symptoms of adrenal insufficiency, especially when the patient lacks a family or personal history of psychiatric illness.
引言艾迪生病是一种相对罕见的由肾上腺功能不全引起的内分泌疾病。精神病症状是其罕见的原发性和特别孤立的临床症状之一。本文报告一例肾上腺功能不全的精神病综合征。病例介绍一名28岁的伊朗女性,从小有免疫性血小板减少性紫癜(ITP)和哮喘病史,有13个月的进行性抑郁症病史,伴有失眠和噩梦症状。在服用氟哌啶醇、克罗米帕明和氯硝西泮八个月后,由于厌食症引起的腹痛和体重减轻开始了。她的身体检查显示,肘部、膝盖、脚踝和口腔粘膜出现皮肤色素沉着。体格检查和初步实验室检查显示肾上腺功能不全。艾迪生病经实验室检查和腹部CT证实,静脉注射氢化可的松后症状明显改善。患者在治疗72小时后保持平静,睡眠正常,没有抑郁症状或精神病。在一年的随访中,患者总体状况良好,没有心理症状。结论精神病性精神障碍可能是Addison病的首发表现。因此,医生应了解肾上腺功能不全的神经精神症状,尤其是当患者没有家族或个人精神病史时。
{"title":"Psychotic Disorder as the First Manifestation of Addison Disease: A Case Report","authors":"Zahra Momayez Sanat, M. Mohajeri-Tehrani","doi":"10.5812/ijem.121011","DOIUrl":"https://doi.org/10.5812/ijem.121011","url":null,"abstract":"Introduction Addison disease is a relatively uncommon endocrine disease resulting from adrenal insufficiency. Psychiatric symptoms are among its rare primary and particularly isolated clinical symptoms. This report presents a case with adrenal insufficiency manifested by the psychotic syndrome. Case Presentation A 28-year-old Iranian female with a history of immune thrombocytopenic purpura (ITP) and asthma since childhood presented with a 13-month history of progressive depression with insomnia and nightmare symptoms. After being prescribed haloperidol, clomipramine, and clonazepam for eight months, abdominal pain and weight loss due to anorexia started. Her physical examination showed skin hyperpigmentation in the elbow, knee, ankle, and buccal mucosa. Physical examination and initial laboratory tests suggested adrenal insufficiency. Addison disease was confirmed according to the laboratory tests and abdominal CT. The symptoms were significantly improved using intravenous hydrocortisone treatment. The patient remained calm and had a normal sleep without depressive symptoms or psychosis after 72 hours of treatment. During one year of follow-up, the patient was in good general condition without psychological symptoms. Conclusions This report shows that psychotic disorder can be the first manifestation of Addison disease. Therefore, physicians should be informed about the neuropsychiatric symptoms of adrenal insufficiency, especially when the patient lacks a family or personal history of psychiatric illness.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44045097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Malignant Endo-suprasellar Glioma: A Case Report and a Brief Review of the Literature 恶性鞍内上胶质瘤1例报告及文献复习
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.5812/ijem.121803
M. Berkovskaya, A. Grigoriev, K. Zhuravlev, V. Fadeev
Introduction Malignant sellar gliomas are very rare phenomena. To date, only few cases of sellar and suprasellar glioblastomas have been reported, most of which originate from the optic nerve or optic chiasm. Case Presentation We present a 34-year-old woman with malignant endo-suprasellar glioma, originating from the pituitary stalk, which was initially classified as a macroprolactinoma. Conclusions Although malignant sellar gliomas can mimic the clinical, endocrinological, and radiological features of pituitary macroadenomas, rapid progression without appropriate hormonal activity suggests their diagnosis. Considering the high malignant potential of sellar glioblastomas, it is important to discuss the specific features of these tumors and to investigate the possibility of differential diagnosis in the preoperative stage, which can be useful for early selection of the treatment plan.
鞍区恶性胶质瘤是非常罕见的现象。到目前为止,只有少数鞍和鞍上胶质母细胞瘤的报道,其中大多数起源于视神经或视交叉。病例介绍我们报告一名34岁的女性,患有恶性鞍上神经胶质瘤,起源于垂体柄,最初被归类为大泌乳素腺瘤。结论尽管鞍区恶性胶质瘤可以模拟垂体大腺瘤的临床、内分泌和放射学特征,但在没有适当激素活性的情况下快速进展提示其诊断。考虑到鞍区胶质母细胞瘤的高恶性潜能,重要的是讨论这些肿瘤的具体特征,并在术前阶段研究鉴别诊断的可能性,这有助于早期选择治疗方案。
{"title":"Malignant Endo-suprasellar Glioma: A Case Report and a Brief Review of the Literature","authors":"M. Berkovskaya, A. Grigoriev, K. Zhuravlev, V. Fadeev","doi":"10.5812/ijem.121803","DOIUrl":"https://doi.org/10.5812/ijem.121803","url":null,"abstract":"Introduction Malignant sellar gliomas are very rare phenomena. To date, only few cases of sellar and suprasellar glioblastomas have been reported, most of which originate from the optic nerve or optic chiasm. Case Presentation We present a 34-year-old woman with malignant endo-suprasellar glioma, originating from the pituitary stalk, which was initially classified as a macroprolactinoma. Conclusions Although malignant sellar gliomas can mimic the clinical, endocrinological, and radiological features of pituitary macroadenomas, rapid progression without appropriate hormonal activity suggests their diagnosis. Considering the high malignant potential of sellar glioblastomas, it is important to discuss the specific features of these tumors and to investigate the possibility of differential diagnosis in the preoperative stage, which can be useful for early selection of the treatment plan.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45785787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Affecting Menstrual Cycle Developmental Trajectory in Adolescents: A Narrative Review 影响青少年月经周期发展轨迹的因素:叙事综述
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.5812/ijem.120438
M. Saei Ghare Naz, M. Farahmand, S. Dashti, F. Ramezani Tehrani
Context The time interval between the age at menarche and regulation of menstrual cycles (menstrual cycle developmental trajectory) is considered an indicator of the function of the reproductive system later in life. This study aimed to summarize the factors affecting this trajectory. Evidence Acquisition A comprehensive literature search in PubMed, Scopus, Google Scholar, and Web of Science was performed to identify studies investigating factors influencing the regularity of the menstrual cycle in adolescents. Results The interval between menarche and the onset of the regular menstrual cycle in adolescent girls may vary from several months to several years. Several factors, including genetic, race/ethnicity, intrauterine situation, social factors, geographical factors, lifestyle, and chronic diseases, are considered the predisposing factors for the trajectory. Conclusions Age at menarche and the onset of regular menstrual cycles are directly and indirectly influenced by several genetic, environmental, and lifestyle factors. Understanding these factors may improve our practice in managing irregular menstrual cycles that commonly happen in the first years after menarche.
月经初潮年龄与月经周期调节(月经周期发育轨迹)之间的时间间隔被认为是生命后期生殖系统功能的一个指标。本研究旨在总结影响这一轨迹的因素。我们在PubMed、Scopus、谷歌Scholar和Web of Science中进行了全面的文献检索,以确定影响青少年月经周期规律的因素。结果青春期少女月经初潮与正常月经周期的间隔可从几个月到几年不等。包括遗传、种族/民族、宫内情况、社会因素、地理因素、生活方式和慢性病在内的几个因素被认为是轨迹的易感因素。结论月经初潮年龄和月经周期的开始受遗传、环境和生活方式等因素的直接或间接影响。了解这些因素可以改善我们在月经初潮后的头几年通常发生的不规则月经周期的管理实践。
{"title":"Factors Affecting Menstrual Cycle Developmental Trajectory in Adolescents: A Narrative Review","authors":"M. Saei Ghare Naz, M. Farahmand, S. Dashti, F. Ramezani Tehrani","doi":"10.5812/ijem.120438","DOIUrl":"https://doi.org/10.5812/ijem.120438","url":null,"abstract":"Context The time interval between the age at menarche and regulation of menstrual cycles (menstrual cycle developmental trajectory) is considered an indicator of the function of the reproductive system later in life. This study aimed to summarize the factors affecting this trajectory. Evidence Acquisition A comprehensive literature search in PubMed, Scopus, Google Scholar, and Web of Science was performed to identify studies investigating factors influencing the regularity of the menstrual cycle in adolescents. Results The interval between menarche and the onset of the regular menstrual cycle in adolescent girls may vary from several months to several years. Several factors, including genetic, race/ethnicity, intrauterine situation, social factors, geographical factors, lifestyle, and chronic diseases, are considered the predisposing factors for the trajectory. Conclusions Age at menarche and the onset of regular menstrual cycles are directly and indirectly influenced by several genetic, environmental, and lifestyle factors. Understanding these factors may improve our practice in managing irregular menstrual cycles that commonly happen in the first years after menarche.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47264837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Wide Spectrum of Thyroid Function Tests in COVID-19: From Nonthyroidal Illness to Isolated Hyperthyroxinemia 新冠肺炎甲状腺功能检测的宽谱:从非甲状腺疾病到孤立性高铁血症
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.5812/ijem.120709
S. Hashemipour, Pouria Shahsavari, Somaieh Kiani, Milad Badri, Arefeh Ghobadi, Seyyed Mohammad Reza Hadizadeh Khairkhahan, Alireza Tariverdi
Background Changes in thyroid function test (TFT) in COVID-19 patients have been reported in several studies. However, some features such as thyrotoxicosis are inconsistent in these studies. In addition, some drugs such as heparin interfere with the free T4 assay. Objectives This study was designed to examine TFT abnormalities in COVID-19, utilizing direct and indirect methods of free T4 assay. Methods This prospective cross-sectional study was conducted on 131 hospitalized COVID-19 patients. Serum levels of total T3, TSH, T3RU, and total T4 were measured. The free T4 assay was performed using direct (free T4) and indirect (free thyroxin index or FT4I) methods. The patients were categorized into different TFT groups. The clinical characteristics, laboratory findings, and outcomes were compared between the groups. Results The frequencies of nonthyroidal illness (NTI), subclinical/overt hypothyroidism and subclinical/overt thyrotoxicosis were 51.7, 6.9, and 6.9%, respectively. Besides, 6 and 8.1% of the patients had isolated high free T4 and isolated high FT4I without any other TFT abnormality, respectively. The lymphocyte percent was lower in the subclinical/overt group than in other TFT groups (P = 0.002). Atrial Fibrillation (AF) was found in 37.5% of subclinical/overt thyrotoxicosis patients versus 1.7% in the NTI and nil in the other three groups (P < 0.001). Conclusions In addition to the reported TFT abnormalities in COVID-19 in previous studies, some new features like isolated hyperthyroxinemia were found in our study. We found a strong association between subclinical/overt thyrotoxicosis and AF. Regarding the high prevalence of AF in hospitalized COVID-19 patients, request for thyroid function test is rational in COVID-19 patients with this arrhythmia.
背景新冠肺炎患者甲状腺功能测试(TFT)的变化已在几项研究中报道。然而,甲状腺毒症等一些特征在这些研究中并不一致。此外,一些药物如肝素会干扰游离T4测定。目的本研究旨在利用游离T4测定的直接和间接方法检测新冠肺炎患者的TFT异常。方法对131例新冠肺炎住院患者进行前瞻性横断面研究。测量血清总T3、TSH、T3RU和总T4的水平。使用直接(游离T4)和间接(游离甲状腺素指数或FT4I)方法进行游离T4测定。将患者分为不同的TFT组。比较两组患者的临床特征、实验室检查结果和结果。结果非甲状腺疾病(NTI)、亚临床/显性甲状腺功能减退症和亚临床/隐性甲状腺毒症的发生率分别为51.7%、6.9%和6.9%。此外,分别有6%和8.1%的患者有孤立的高游离T4和孤立的高FT4I,没有任何其他TFT异常。亚临床/显性组的淋巴细胞百分比低于其他TFT组(P=0.002)。37.5%的亚临床/隐性甲状腺毒症患者出现心房颤动(AF),而NTI患者为1.7%,其他三组为零(P<0.001),我们的研究发现了一些新的特征,如孤立的高甲状腺素血症。我们发现亚临床/显性甲状腺毒症与房颤之间有很强的相关性。考虑到住院新冠肺炎患者中房颤的高患病率,对患有这种心律失常的新冠肺炎患者进行甲状腺功能测试的要求是合理的。
{"title":"Wide Spectrum of Thyroid Function Tests in COVID-19: From Nonthyroidal Illness to Isolated Hyperthyroxinemia","authors":"S. Hashemipour, Pouria Shahsavari, Somaieh Kiani, Milad Badri, Arefeh Ghobadi, Seyyed Mohammad Reza Hadizadeh Khairkhahan, Alireza Tariverdi","doi":"10.5812/ijem.120709","DOIUrl":"https://doi.org/10.5812/ijem.120709","url":null,"abstract":"Background Changes in thyroid function test (TFT) in COVID-19 patients have been reported in several studies. However, some features such as thyrotoxicosis are inconsistent in these studies. In addition, some drugs such as heparin interfere with the free T4 assay. Objectives This study was designed to examine TFT abnormalities in COVID-19, utilizing direct and indirect methods of free T4 assay. Methods This prospective cross-sectional study was conducted on 131 hospitalized COVID-19 patients. Serum levels of total T3, TSH, T3RU, and total T4 were measured. The free T4 assay was performed using direct (free T4) and indirect (free thyroxin index or FT4I) methods. The patients were categorized into different TFT groups. The clinical characteristics, laboratory findings, and outcomes were compared between the groups. Results The frequencies of nonthyroidal illness (NTI), subclinical/overt hypothyroidism and subclinical/overt thyrotoxicosis were 51.7, 6.9, and 6.9%, respectively. Besides, 6 and 8.1% of the patients had isolated high free T4 and isolated high FT4I without any other TFT abnormality, respectively. The lymphocyte percent was lower in the subclinical/overt group than in other TFT groups (P = 0.002). Atrial Fibrillation (AF) was found in 37.5% of subclinical/overt thyrotoxicosis patients versus 1.7% in the NTI and nil in the other three groups (P < 0.001). Conclusions In addition to the reported TFT abnormalities in COVID-19 in previous studies, some new features like isolated hyperthyroxinemia were found in our study. We found a strong association between subclinical/overt thyrotoxicosis and AF. Regarding the high prevalence of AF in hospitalized COVID-19 patients, request for thyroid function test is rational in COVID-19 patients with this arrhythmia.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43180273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
International Journal of Endocrinology and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1